Midkine in glioblastoma with the modulator role switching autophagy to cell death or cell survival
Abstract
Glioblastoma (GBM) is the most common and lethal brain tumor. Characterization of GBM with poor prognosis although new treatment modalities hasn't been changed up to date. New molecular targets in order to overcome resistance and recurrence are needed. Au
URI
https://doi.org/10.1007/978-94-007-4234-5_25http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1549
Collections
DSpace@İYYU by Istanbul Yeni Yüzyil University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..
